Hillenbrand (NYSE: HI), Milacron’s current owner, will continue to remain a significant investor in the business. BOSTON & BATESVILLE, Ind.--(BUSINESS WIRE)--Bain Capital, a leading private investment ...
Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...
An affiliate of Bain Capital will acquire 51 per cent of the injection molding and extrusion machinery maker from current owner Hillenbrand Inc.
According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.
On February 5, the company entered into a definitive agreement to sell an ownership stake of approximately 51% in its Milacron injection ...
Key alts deals unveiled today include Silver Point's $250 million CLO fund close, Bain Capital's stake in manufacturer Milacron, a KKR-backed tech acquisition.
Taking a look at a Graham Partners-backed technology company that is pursuing a continuation vehicle funding after running a ...
The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...
U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...
Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...
The provider of highly-engineered processing equipment and solutions will sell a 51% stake in the injection molding and extrusion business for $287 million.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback